Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Prior Information Notice

Attention Deficit Hyperactivity Disorder (ADHD) Assessment Service for NHS Shropshire Telford and Wrekin Integrated Care Board

  • First published: 09 February 2024
  • Last modified: 09 February 2024

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-h6vhtk-043828
Published by:
NHS Shropshire, Telford and Wrekin Integrated Care Board
Authority ID:
AA83140
Publication date:
09 February 2024
Deadline date:
-
Notice type:
Prior Information Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

This is an advertisement for soft market testing to gauge market interest which will influence future commissioning and procurement direction.

NHS Shropshire Telford and Wrekin Integrated Care Board (STW ICB) are looking to seek expressions of interest and to engage with suitably qualified and experienced Providers with regards to the commissioning of a

• Attention Deficit Hyperactivity Disorder(ADHD) Assessment Service

The ICB are looking to host a Market Engagement Event with potential providers via Microsoft Teams on Thursday 22nd February 2024, timings to be confirmed.

The Service will consist of:

• Providing a specialist assessment and diagnostic service to adults with a suspected ADHD residing within the local areas as defined by the ICB commissioning boundaries.

• This service is for the triage ,assessment, diagnosis and establishing treatment for adult patients with ADHD symptoms and is designed to provide a safe and effective service within the community to patients across STW with a suspected ADHD diagnosis which may require pharmacological and/or non-pharmacological treatment for ADHD as appropriate on confirmed diagnosis.

• This service will assess and diagnose individuals with suspected ADHD across STW who do not have serious mental health comorbidities.

To provide a safe and effective service the service will:

• Provide initial assessment and timely diagnosis of ADHD in adults and establish a treatment plan to include pharmacological and/or non-pharmacological treatment which also addresses the individuals psychological, behavioural, and occupational or educational needs.

• Provide relevant advice, guidance, support and signposting to appropriate organisations and other professionals as appropriate.

• Initiation of medication that aligns to NHS STW ICS local health formulary: Formulary(shropshireandtelfordformulary.nhs.uk).

• Provide the specialist element of oversight of prescribing including all baseline physical health checks and ongoing monitoring as appropriate as detailed by the Integrated Care Protocol (ICP) prior to transfer/acceptance to oversight/monitoring service or any other appropriate provider.

• Provide guidance on self-help strategies and recommendations for individuals in support of self-care.

It is anticipated that any future Contract would be for a period of 1 year with the option to

extend for up to a further 12 months with an estimated value of £3,200,000.00. NHS Standard Terms and Conditions would apply.

Should you be interest in attending please respond via Atamishttps://health-family.force.com/s/Welcome no later than 16:00 hours on Friday 16th February 2024.

The ICB are aware of their transparency obligations under the Provider Selection Regime. Please note for those providers expressing interest to attend this market engagement event, this does not guarantee that they will not be required to register for any future provider selection process, and they should not rely on their response to this Expressions of Interest notice as confirmation that the ICB will proceed further.

Full notice text

Prior information notice

This notice is for prior information only

Section I: Contracting authority

I.1) Name and addresses

NHS Shropshire, Telford and Wrekin Integrated Care Board

Civic Offices, Larkin Way, Tan Bank, Wellington

Telford

TF1 1LX

UK

Contact person: Hayley Smith

Telephone: +44 7770493216

E-mail: h.smith27@nhs.net

NUTS: UKG21

Internet address(es)

Main address: https://www.shropshiretelfordandwrekin.nhs.uk/

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://health-family.force.com/s/Welcome


Additional information can be obtained from the abovementioned address


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Attention Deficit Hyperactivity Disorder (ADHD) Assessment Service for NHS Shropshire Telford and Wrekin Integrated Care Board

Reference number: WHISP-184

II.1.2) Main CPV code

85100000

 

II.1.3) Type of contract

Services

II.1.4) Short description

This is an advertisement for soft market testing to gauge market interest which will influence future commissioning and procurement direction.

NHS Shropshire Telford and Wrekin Integrated Care Board (STW ICB) are looking to seek expressions of interest and to engage with suitably qualified and experienced Providers with regards to the commissioning of a

• Attention Deficit Hyperactivity Disorder(ADHD) Assessment Service

The ICB are looking to host a Market Engagement Event with potential providers via Microsoft Teams on Thursday 22nd February 2024, timings to be confirmed.

Should you be interest in attending please respond via Atamis no later than 16:00 hours on Friday 16th February 2024.

II.1.5) Estimated total value

Value excluding VAT: 3 200 000.00  GBP

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.3) Place of performance

NUTS code:

UKG21

UKG22


Main site or place of performance:

County of Shropshire.

II.2.4) Description of the procurement

This is an advertisement for soft market testing to gauge market interest which will influence future commissioning and procurement direction.

NHS Shropshire Telford and Wrekin Integrated Care Board (STW ICB) are looking to seek expressions of interest and to engage with suitably qualified and experienced Providers with regards to the commissioning of a

• Attention Deficit Hyperactivity Disorder(ADHD) Assessment Service

The ICB are looking to host a Market Engagement Event with potential providers via Microsoft Teams on Thursday 22nd February 2024, timings to be confirmed.

The Service will consist of:

• Providing a specialist assessment and diagnostic service to adults with a suspected ADHD residing within the local areas as defined by the ICB commissioning boundaries.

• This service is for the triage ,assessment, diagnosis and establishing treatment for adult patients with ADHD symptoms and is designed to provide a safe and effective service within the community to patients across STW with a suspected ADHD diagnosis which may require pharmacological and/or non-pharmacological treatment for ADHD as appropriate on confirmed diagnosis.

• This service will assess and diagnose individuals with suspected ADHD across STW who do not have serious mental health comorbidities.

To provide a safe and effective service the service will:

• Provide initial assessment and timely diagnosis of ADHD in adults and establish a treatment plan to include pharmacological and/or non-pharmacological treatment which also addresses the individuals psychological, behavioural, and occupational or educational needs.

• Provide relevant advice, guidance, support and signposting to appropriate organisations and other professionals as appropriate.

• Initiation of medication that aligns to NHS STW ICS local health formulary: Formulary(shropshireandtelfordformulary.nhs.uk).

• Provide the specialist element of oversight of prescribing including all baseline physical health checks and ongoing monitoring as appropriate as detailed by the Integrated Care Protocol (ICP) prior to transfer/acceptance to oversight/monitoring service or any other appropriate provider.

• Provide guidance on self-help strategies and recommendations for individuals in support of self-care.

It is anticipated that any future Contract would be for a period of 1 year with the option to

extend for up to a further 12 months with an estimated value of £3,200,000.00. NHS Standard Terms and Conditions would apply.

Should you be interest in attending please respond via Atamishttps://health-family.force.com/s/Welcome no later than 16:00 hours on Friday 16th February 2024.

The ICB are aware of their transparency obligations under the Provider Selection Regime. Please note for those providers expressing interest to attend this market engagement event, this does not guarantee that they will not be required to register for any future provider selection process, and they should not rely on their response to this Expressions of Interest notice as confirmation that the ICB will proceed further.

II.3) Estimated date of publication of contract notice:

01/04/2024

Section IV: Procedure

IV.1) Description

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

Section VI: Complementary information

VI.3) Additional information

It should be noted that this is not a procurement exercise at this stage and participating organisations are responsible for their own costs. All details provided by the ICB are in draft

format, the ICB reserves the right to change/amend any aspect of the requirement prior to any potential future procurement exercise.

To register your Expression of Interest (EOI) in attending the Market Engagement event,

please complete the questionnaire on the Atamis Health Family eCommercial System

https://health-family.force.com/s/Welcome. Atamis Reference C244545.

The closing date for EOIs is 16:00hours on Friday 16th February 2024.

This is a Provider Selection Regime(PSR) intended market engagement event notice. Should the ICB award any contract subsequent to this event, it will be subject to the Health Care Services(Provider Selection Regime)Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this notice.

The ICB is not bound to act on any information generated from the market engagement, and participation in the event does not automatically guarantee any standing with regards to any future PSR process adopted by the ICB.

VI.5) Date of dispatch of this notice

08/02/2024

Coding

Commodity categories

ID Title Parent category
85100000 Health services Health and social work services

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
h.smith27@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.